Form 4: Aramark Director Karen Marie King Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Karen Marie King reports acquisition of dividend equivalent rights and disposal of common stock.
Summary
- On May 28, 2024, Karen Marie King, a director of Aramark, reported acquiring 36.728 dividend equivalent rights related to deferred stock units.
- These rights are tied to Aramark's quarterly dividend and vest according to the same schedule as the underlying awards.
- King also reported disposing of common stock, resulting in a decrease in holdings to 32,479.651 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing changes in beneficial ownership. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The acquisition of dividend equivalent rights suggests continued alignment of the director's interests with those of shareholders.
Negatives
- The disposal of common stock may be viewed negatively by some investors, although the reason for the disposal is not specified.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking to understand management's perspective on the company's stock.
Stakeholder Impact
- Shareholders may be interested in the director's transactions as an indicator of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 05/28/2024 | Date of transaction involving dividend equivalent rights and common stock. |
| 05/30/2024 | Date of signature by attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.